Tag: hepatocellular carcinoma (HCC)

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial The optimal duration of androgen suppression therapy with radiotherapy for locally advanced prostate cancer is...

1. In a retrospective study of 111 patients with hepatocellular carcinoma (HCC) with extrahepatic spread (EHS) treated with transarterial chemoembolization (TACE), median overall survival was 3.8 months. 2. Maximum tumor size ≥10 cm, the presence of multifocal intrahepatic tumors, and portal vein tumor thrombosis were elucidated as indicators of poor...